Loading...
XHKG
1858
Market cap1.24bUSD
Dec 05, Last price  
16.20HKD
1D
-1.28%
1Q
-6.90%
Jan 2017
542.86%
IPO
7.00%
Name

Beijing Chunlizhengda Medical Instruments Co Ltd

Chart & Performance

D1W1MN
XHKG:1858 chart
P/E
70.07
P/S
10.87
EPS
0.21
Div Yield, %
3.02%
Shrs. gr., 5y
1.91%
Rev. gr., 5y
-1.18%
Revenues
806m
-33.32%
98,094,696110,545,519134,534,445177,368,809207,926,096300,317,298497,927,159855,326,545937,686,1851,108,139,5201,201,604,2541,208,523,845805,857,022
Net income
125m
-55.01%
31,939,63632,665,36137,031,19737,865,61763,440,59068,283,986105,646,070236,761,397283,373,280322,360,736307,719,145277,824,014124,988,009
CFO
-2m
L
28,827,96928,202,52724,274,585064,945,27289,833,114108,506,202231,540,264260,682,359164,785,78641,007,526511,713,888-1,899,550
Dividend
Jun 30, 20250.05247388 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. It offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. The company primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. It also exports its products to various countries. The company was incorporated in 1998 and is headquartered in Beijing, China.
IPO date
Dec 30, 2021
Employees
1,379
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT